Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-78,887
Closed -$3.2M 1149
2025
Q4
$3.2M Buy
78,887
+260
+0.3% +$11.3K 0.11% 245
2025
Q3
$3.7M Buy
78,627
+2,157
+3% +$112K 0.14% 207
2025
Q2
$3.98M Sell
76,470
-758
-1% -$41.6K 0.2% 132
2025
Q1
$4.66M Buy
+77,228
New +$4.98M 0.28% 92
2019
Q4
Sell
-11,422
Closed -$1.1M 1578
2019
Q3
$1.1M Buy
+11,422
New +$1.07M 0.01% 789
2018
Q3
Sell
-7,969
Closed -$583K 1027
2018
Q2
$583K Sell
7,969
-94,943
-92% -$6.46M 0.01% 595
2018
Q1
$6.52M Buy
+102,912
New +$6.14M 0.18% 151

Other funds holding CNMD

Winton Group's CNMD Position: Q1 2026 in Review

Winton Group sold out of CONMED (CNMD) in Q1 2026, closing a stake of 78,887 shares — an estimated $3.2M sold.

Winton Group first reported a position in CNMD in Q1 2018 and held it in 7 quarters. The position peaked at $6.52M in Q1 2018. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Winton Group reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Winton Group sold 78,887 CONMED shares in Q1 2026, an estimated $3.2M.
  • Winton Group first reported a position in CONMED in Q1 2018 and held it in 7 quarters.
  • Winton Group's CONMED position peaked at $6.52M in Q1 2018.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Winton Group's 13F filing for Q1 2026, filed 12 May 2026.